Kevin Eisenfrats

Kevin Eisenfrats

entrepreneur United States

Kevin Eisenfrats is the founder and chief executive of Contraline, a company that is pioneering non-hormonal male contraceptive solutions. He has been instrumental in developing 'Adam', an innovative implantable hydrogel contraceptive that effectively blocks sperm release for up to two years. Eisenfrats is driven by the goal of providing a reversible alternative to traditional contraceptive methods, with a focus on user-friendly and minimally invasive procedures.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Ghana Ghana: Kevin Eisenfrats is the founder and chief executive of Contraline, which developed the Adam contraceptive implant. 9

Daily Graphic – state-owned Ghanaian newspaper, est. 1950: Non-hormonal male contraceptive implant lasts at least two years in trials

Malaysia Malaysia: Kevin Eisenfrats is the CEO and founder of Contraline, which is developing a male contraceptive implant. 9

Utusan Malaysia: Implan kontraseptif lelaki mampu bertahan dua tahun

United Kingdom United Kingdom: Kevin Eisenfrats is the founder and chief executive of Contraline, which developed the Adam contraceptive implant. 9

The Guardian: Non-hormonal male contraceptive implant lasts at least two years in trials | Medical research